SWI/SNF complex alterations as a biomarker of immunotherapy efficacy in pancreatic cancer-Reference-Cited by-同舟云学术

SWI/SNF complex alterations as a biomarker of immunotherapy efficacy in pancreatic cancer

Published:2021-09-22 Issue:18 Volume:6 Page:
ISSN:2379-3708
Container-title:JCI Insight
language:en
Short-container-title:

Author:

Botta Gregory P.^ORCID,Kato Shumei,Patel Hitendra,Fanta Paul,Lee Suzanna^ORCID,Okamura Ryosuke^ORCID,Kurzrock Razelle^ORCID

Funder

NIH Clinical Center

Publisher

American Society for Clinical Investigation

Subject

General Medicine

Link

https://insight.jci.org/articles/view/150453/files/pdf

Reference63 articles.

1. American Cancer Society. Cancer Facts & Figures 2019. https://www.cancer.org/research/cancer-facts-statistics/all-cancer-facts-figures/cancer-facts-figures-2019.html Accessed August 6, 2021

2. Multi-institutional Validation Study of the American Joint Commission on Cancer (8th Edition) Changes for T and N Staging in Patients With Pancreatic Adenocarcinoma

3. National Cancer Institute. Pancreas SEER Survival Rates by Time Since Diagnosis, 2000-2017. https://seer.cancer.gov/explorer/application.html?site=40&data_type=4&graph_type=6&compareBy=stage&chk_stage_101=101&chk_stage_104=104&chk_stage_105=105&chk_stage_106=106&chk_stage_107=107&sex=1&race=1&age_range=1&advopt_precision=1&advopt_show_ci=on Accessed August 6, 2021

4. Increased Survival in Pancreatic Cancer with nab-Paclitaxel plus Gemcitabine

5. FOLFIRINOX versus Gemcitabine for Metastatic Pancreatic Cancer

Cited by 41 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The Landscape and Prognosis of Microsatellite Stable (MSS) Esophageal, Gastro-Esophageal Junction and Gastric Adenocarcinomas with High Tumor Mutation Burden (TMB);Cancer Investigation;2024-08-08

2. Preclinical evidence in the assembly of mammalian SWI/SNF complexes: Epigenetic insights and clinical perspectives in human lung disease therapy;Molecular Therapy;2024-08

3. Current development of molecular classifications of gastric cancer based on omics (Review);International Journal of Oncology;2024-08-01

4. First-line penpulimab (an anti-PD1 antibody) and anlotinib (an angiogenesis inhibitor) with nab-paclitaxel/gemcitabine (PAAG) in metastatic pancreatic cancer: a prospective, multicentre, biomolecular exploratory, phase II trial;Signal Transduction and Targeted Therapy;2024-06-07

5. ARID1A suppresses R-loop-mediated STING-type I interferon pathway activation of anti-tumor immunity;Cell;2024-06